Article

Dr. Niteesh Choudhry Discusses Value-Based Insurance Design [Part 1 of 4]

Dr. Niteesh Choudhry, Associate Professor, Harvard Medical School, Division of Pharmacoepidemiology and Pharmacoeconomics in Boston, discusses VBID and how looming questions revealed from this study show the model’s importance as well as its need to be better defined.

Dr. Choudhry explains that a key method to better defining VBID is to conduct similar studies within other specialties to learn about outcomes when the model is applied to diseases such as diabetes, hypertension, and hyperlipidemia.

Related Videos
Dr Chun Chao
Screenshot of an interview with Shaun McKenzie, MD
Brianna Rhue, OD, FAAO
Julie Rodman, OD, MS, FAAO
Nate Lighthizer, OD, FAAO
Lidia Schapira, MD, FASCO, professor of medicine at Stanford Medicine, medical oncologist, and director for the Stanford Cancer Institute and the Stanford Comprehensive Cancer Center
Mile Brujic, OD, FAAO
Tiffany Meng, PharmD, oncology pharmacist, UCSF Health
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo